Expert Opinion on Drug Metabolism and Toxicology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.5 | Q1 | 76.4% | 0.986 | Q1 | 83.6% |
| 2024 | 3.4 | Q2 | 68.9% | 0.986 | Q1 | 83.9% |
| 2023 | 3.9 | Q1 | 79.6% | 0.987 | Q1 | 85.2% |
| 2022 | 4.3 | Q1 | 79.6% | 0.895 | Q1 | 83.6% |
| 2021 | 4.9 | Q1 | 79.4% | 0.920 | Q1 | 84.7% |
| 2020 | — | — | 1.031 | Q1 | 85.9% | |
| 2019 | — | — | 0.930 | Q1 | 84.1% | |
| 2018 | — | — | 0.896 | Q1 | 81.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1744-7607
ISSN
1742-5255
country
GBcoverage
2005-2026